REGN Filing
10-KFiling Date: Feb 4, 2026

REGENERON PHARMACEUTICALS, INC. (REGN) · Annual Report (10-K) SEC Filing

regn-20251231

descriptionView SEC Filing
ACC: 0000872589-26-000008open_in_new
Key Financial Metrics2025 · 2025-12-31
Revenue$14.34B
Net Income$4.50B
Total Assets$40.56B
Stockholders' Equity$35.80B
Operating Cash Flow$4.98B

keid AI analysis is for reference only and does not constitute investment advice.